RUBY — Rubius Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Rubius Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	404	283	176	226	14.9
Prepaid Expenses
Total Other Current Assets
Total Current Assets	414	289	182	230	20.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	62.8	103	94.4	86.6	2.83
Other Long Term Assets
Total Assets	479	395	278	318	23.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	20	33.8	27.8	34.7	7.94
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	86.1	121	136	139	7.94
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	393	274	142	179	15.1
Total Liabilities & Shareholders' Equity	479	395	278	318	23.1
Total Common Shares Outstanding